BNP Paribas Financial Markets’s Revance Therapeutics, Inc. RVNC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,662
Closed -$41.5K 4681
2024
Q4
$41.5K Sell
13,662
-10,728
-44% -$32.6K ﹤0.01% 3650
2024
Q3
$127K Sell
24,390
-90,901
-79% -$472K ﹤0.01% 2681
2024
Q2
$296K Sell
115,291
-96,404
-46% -$248K ﹤0.01% 2280
2024
Q1
$1.04M Buy
211,695
+163,809
+342% +$806K ﹤0.01% 1872
2023
Q4
$421K Sell
47,886
-94,416
-66% -$830K ﹤0.01% 2201
2023
Q3
$1.63M Sell
142,302
-79,507
-36% -$912K ﹤0.01% 1466
2023
Q2
$5.61M Sell
221,809
-83,372
-27% -$2.11M 0.01% 838
2023
Q1
$9.83M Buy
305,181
+82,382
+37% +$2.65M 0.01% 651
2022
Q4
$4.11M Buy
+222,799
New +$4.11M 0.01% 975
2022
Q3
Sell
-16,721
Closed -$231K 4243
2022
Q2
$231K Buy
16,721
+9,445
+130% +$131K ﹤0.01% 2399
2022
Q1
$142K Sell
7,276
-8,689
-54% -$169K ﹤0.01% 2685
2021
Q4
$261K Sell
15,965
-1,203
-7% -$19.6K ﹤0.01% 2658
2021
Q3
$478K Buy
17,168
+8,443
+97% +$235K ﹤0.01% 2200
2021
Q2
$259K Sell
8,725
-10,254
-54% -$304K ﹤0.01% 2224
2021
Q1
$530K Buy
18,979
+6,810
+56% +$190K ﹤0.01% 2009
2020
Q4
$345K Sell
12,169
-2,710
-18% -$76.8K ﹤0.01% 2014
2020
Q3
$374K Buy
14,879
+12,526
+532% +$315K ﹤0.01% 1807
2020
Q2
$57.5K Sell
2,353
-13,342
-85% -$326K ﹤0.01% 2362
2020
Q1
$232K Buy
15,695
+10,434
+198% +$154K ﹤0.01% 2203
2019
Q4
$85.4K Sell
5,261
-1,094
-17% -$17.8K ﹤0.01% 2704
2019
Q3
$82.6K Buy
6,355
+2,087
+49% +$27.1K ﹤0.01% 2592
2019
Q2
$55.4K Sell
4,268
-3,691
-46% -$47.9K ﹤0.01% 2745
2019
Q1
$125K Buy
+7,959
New +$125K ﹤0.01% 2414
2018
Q4
Sell
-1,035
Closed -$25.7K 3730
2018
Q3
$25.7K Hold
1,035
﹤0.01% 2650
2018
Q2
$28.4K Sell
1,035
-4,494
-81% -$123K ﹤0.01% 2708
2018
Q1
$170K Buy
5,529
+680
+14% +$20.9K ﹤0.01% 2334
2017
Q4
$173K Buy
4,849
+2,696
+125% +$96.4K ﹤0.01% 2387
2017
Q3
$59.3K Sell
2,153
-148
-6% -$4.08K ﹤0.01% 2623
2017
Q2
$60.7K Buy
2,301
+2,174
+1,712% +$57.4K ﹤0.01% 2625
2017
Q1
$2.64K Sell
127
-1,019
-89% -$21.2K ﹤0.01% 2902
2016
Q4
$23.7K Sell
1,146
-411
-26% -$8.51K ﹤0.01% 2620
2016
Q3
$25.2K Buy
1,557
+577
+59% +$9.35K ﹤0.01% 2766
2016
Q2
$13.3K Buy
+980
New +$13.3K ﹤0.01% 2763
2016
Q1
Sell
-3,934
Closed -$134K 3124
2015
Q4
$134K Buy
3,934
+651
+20% +$22.2K ﹤0.01% 2153
2015
Q3
$97.7K Buy
3,283
+1,981
+152% +$59K ﹤0.01% 2410
2015
Q2
$41.6K Buy
1,302
+1,106
+564% +$35.4K ﹤0.01% 2600
2015
Q1
$4.06K Buy
+196
New +$4.06K ﹤0.01% 3259
2014
Q4
Sell
-408
Closed -$7.89K 2853
2014
Q3
$7.89K Buy
+408
New +$7.89K ﹤0.01% 3194